Matinas BioPharma Holdings Inc MTNB:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:47 PM EDT
0.1865quote price arrow up+0.0008 (+0.4308%)
Volume
144,094
52 week range
0.11 - 0.89
Loading...
  • Open0.1848
  • Day High0.19
  • Day Low0.1848
  • Prev Close0.1857
  • 52 Week High0.89
  • 52 Week High Date10/11/23
  • 52 Week Low0.11
  • 52 Week Low Date08/10/23

Key Stats

  • Market Cap46.777M
  • Shares Out250.82M
  • 10 Day Average Volume0.93M
  • Dividend-
  • Dividend Yield-
  • Beta1.63
  • YTD % Change-13.46

KEY STATS

  • Open0.1848
  • Day High0.19
  • Day Low0.1848
  • Prev Close0.1857
  • 52 Week High0.89
  • 52 Week High Date10/11/23
  • 52 Week Low0.11
  • 52 Week Low Date08/10/23
  • Market Cap46.777M
  • Shares Out250.82M
  • 10 Day Average Volume0.93M
  • Dividend-
  • Dividend Yield-
  • Beta1.63
  • YTD % Change-13.46

RATIOS/PROFITABILITY

  • EPS (TTM)-0.11
  • P/E (TTM)-1.77
  • Fwd P/E (NTM)-1.70
  • EBITDA (TTM)-23.373M
  • ROE (TTM)-82.11%
  • Revenue (TTM)1.096M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,093.25%
  • Debt To Equity (MRQ)0.12%

EVENTS

  • Earnings Date05/08/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Matinas BioPharma Holdings Inc

 

Profile

MORE
Matinas BioPharma Holdings, Inc. is a biopharmaceutical company. The Company is focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology (LNC Platform). Its lead product candidate is MAT2203 (oral amphotericin B), a highly potent antifungal drug which, by virtue of LNC delivery, has been made oral, safe, and well-tolerated for prolonged administration in patients with life-threatening invasive fungal infections. MAT2203 is...
Eric Ende M.D.
Independent Chairman of the Board
Jerome Jabbour J.D.
President, Chief Executive Officer, Director
Keith Kucinski CPA
Chief Financial Officer
Hui Liu Ph.D.
Chief Technology Officer
Address
Suite 302, 1545 Route 206 South
Bedminster, NJ
07921
United States

Top Peers

SYMBOLLASTCHG%CHG
CLNN
Clene Inc.
0.4215-0.0103-2.3854%
TIL
Instil Bio Inc
10.68-0.14-1.29%
INAB
IN8BIO, Inc.
1.02UNCHUNCH
QNCX
Quince Therapeutics Inc
1.05-0.02-1.87%
IMRX
Immuneering Corp
1.43+0.01+0.70%